Please use this identifier to cite or link to this item: https://hdl.handle.net/11147/5405
Full metadata record
DC FieldValueLanguage
dc.contributor.authorÖmür, Özgür-
dc.contributor.authorBaran, Yusuf-
dc.date.accessioned2017-04-26T07:30:58Z-
dc.date.available2017-04-26T07:30:58Z-
dc.date.issued2014-01-
dc.identifier.citationÖmür, Ö., and Baran, Y. (2014). An update on molecular biology of thyroid cancers. Critical Reviews in Oncology/Hematology, 90(3), 233-252. doi:10.1016/j.critrevonc.2013.12.007en_US
dc.identifier.issn1040-8428-
dc.identifier.urihttp://doi.org/10.1016/j.critrevonc.2013.12.007-
dc.identifier.urihttp://hdl.handle.net/11147/5405-
dc.description.abstractDifferentiated thyroid cancer (DTC) is the most common endocrinological malignancy. There are several histological variants such as papillary and follicular thyroid carcinoma. Many patients with well-differentiated subtypes of DTC are cured by surgery alone or with radioiodine, while poorly differentiated types usually have a worse prognosis. The aggressiveness of thyroid tumors is closely linked to specific gene alterations.Several diagnostic and prognostic molecular markers such as BRAF and RAS point mutations; RET/PTC and PAX8/PPARγ gene rearrangements; MAPK, PI3K, p53, Wnt-beta catenin, HIF1α and NF-kappaB signaling pathways; microRNA profiles and aberrant methylation have been demonstrated in more than 70% of DTC. Diagnostic use of these molecular markers may be optimized for identifying higher risks of mortality, tumor recurrence and metastatic potential. Understanding the molecular biology of thyroid cancers can be an important avenue for diagnosis and treatment of radioiodine-refractory or inoperable DTC patients with novel molecular targeted therapeutic agents. © 2014 Elsevier Ireland Ltd.en_US
dc.language.isoenen_US
dc.publisherElsevier Ltd.en_US
dc.relation.ispartofCritical Reviews in Oncology/Hematologyen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBRAFen_US
dc.subjectDifferentiated thyroid canceren_US
dc.subjectThyroid canceren_US
dc.subjectRET/PTCen_US
dc.subjectPAX8/PPARγen_US
dc.subjectTumor markersen_US
dc.titleAn update on molecular biology of thyroid cancersen_US
dc.typeArticleen_US
dc.institutionauthorBaran, Yusuf-
dc.departmentİzmir Institute of Technology. Molecular Biology and Geneticsen_US
dc.identifier.volume90en_US
dc.identifier.issue3en_US
dc.identifier.startpage233en_US
dc.identifier.endpage252en_US
dc.identifier.wosWOS:000337774900005en_US
dc.identifier.scopus2-s2.0-84899917464en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.1016/j.critrevonc.2013.12.007-
dc.identifier.pmid24405857en_US
dc.relation.doi10.1016/j.critrevonc.2013.12.007en_US
dc.coverage.doi10.1016/j.critrevonc.2013.12.007en_US
dc.identifier.wosqualityQ1-
dc.identifier.scopusqualityQ1-
item.openairetypeArticle-
item.cerifentitytypePublications-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextWith Fulltext-
item.grantfulltextopen-
crisitem.author.dept04.03. Department of Molecular Biology and Genetics-
Appears in Collections:Molecular Biology and Genetics / Moleküler Biyoloji ve Genetik
PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Files in This Item:
File Description SizeFormat 
5405.pdfİnceleme (Review)2.97 MBAdobe PDFThumbnail
View/Open
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

79
checked on Feb 16, 2024

WEB OF SCIENCETM
Citations

75
checked on Feb 17, 2024

Page view(s)

166
checked on Feb 26, 2024

Download(s)

714
checked on Feb 26, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.